vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and MID PENN BANCORP INC (MPB). Click either name above to swap in a different company.

Immunocore Holdings plc is the larger business by last-quarter revenue ($104.5M vs $62.0M, roughly 1.7× MID PENN BANCORP INC). On growth, MID PENN BANCORP INC posted the faster year-over-year revenue change (30.8% vs 24.3%). MID PENN BANCORP INC produced more free cash flow last quarter ($71.8M vs $-35.5M). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs 21.1%).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

Commerce Bancorp was a Cherry Hill, New Jersey–based bank created in 1973. In 2007, it was purchased by Toronto-Dominion Bank, which merged Commerce into TD Banknorth, the latter of which was rebranded to TD Bank.

IMCR vs MPB — Head-to-Head

Bigger by revenue
IMCR
IMCR
1.7× larger
IMCR
$104.5M
$62.0M
MPB
Growing faster (revenue YoY)
MPB
MPB
+6.5% gap
MPB
30.8%
24.3%
IMCR
More free cash flow
MPB
MPB
$107.3M more FCF
MPB
$71.8M
$-35.5M
IMCR
Faster 2-yr revenue CAGR
IMCR
IMCR
Annualised
IMCR
21.7%
21.1%
MPB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMCR
IMCR
MPB
MPB
Revenue
$104.5M
$62.0M
Net Profit
$19.4M
Gross Margin
97.4%
Operating Margin
-18.8%
43.6%
Net Margin
31.4%
Revenue YoY
24.3%
30.8%
Net Profit YoY
47.0%
EPS (diluted)
$-0.61
$0.83

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
MPB
MPB
Q4 25
$104.5M
$62.0M
Q3 25
$103.7M
$61.8M
Q2 25
$98.0M
$54.3M
Q1 25
$93.9M
$47.7M
Q4 24
$84.1M
$47.4M
Q3 24
$80.2M
$45.3M
Q2 24
$75.4M
$44.1M
Q1 24
$70.5M
$42.3M
Net Profit
IMCR
IMCR
MPB
MPB
Q4 25
$19.4M
Q3 25
$-177.0K
$18.3M
Q2 25
$-10.3M
$4.8M
Q1 25
$5.0M
$13.7M
Q4 24
$13.2M
Q3 24
$8.7M
$12.3M
Q2 24
$-11.6M
$11.8M
Q1 24
$-24.4M
$12.1M
Gross Margin
IMCR
IMCR
MPB
MPB
Q4 25
97.4%
Q3 25
99.5%
Q2 25
98.9%
Q1 25
99.1%
Q4 24
99.6%
Q3 24
99.4%
Q2 24
97.7%
Q1 24
99.7%
Operating Margin
IMCR
IMCR
MPB
MPB
Q4 25
-18.8%
43.6%
Q3 25
-6.9%
39.3%
Q2 25
-15.2%
7.9%
Q1 25
-3.9%
35.2%
Q4 24
-23.1%
34.1%
Q3 24
-10.6%
32.8%
Q2 24
-21.2%
32.4%
Q1 24
-37.6%
34.8%
Net Margin
IMCR
IMCR
MPB
MPB
Q4 25
31.4%
Q3 25
-0.2%
29.6%
Q2 25
-10.5%
8.8%
Q1 25
5.4%
28.8%
Q4 24
27.9%
Q3 24
10.9%
27.1%
Q2 24
-15.4%
26.7%
Q1 24
-34.7%
28.7%
EPS (diluted)
IMCR
IMCR
MPB
MPB
Q4 25
$-0.61
$0.83
Q3 25
$0.00
$0.79
Q2 25
$-0.20
$0.22
Q1 25
$0.10
$0.71
Q4 24
$-0.47
$0.72
Q3 24
$0.17
$0.74
Q2 24
$-0.23
$0.71
Q1 24
$-0.49
$0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
MPB
MPB
Cash + ST InvestmentsLiquidity on hand
$864.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$381.0M
$814.1M
Total Assets
$1.1B
$6.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
MPB
MPB
Q4 25
$864.2M
Q3 25
$892.4M
Q2 25
$882.8M
Q1 25
$837.0M
Q4 24
$820.4M
Q3 24
$901.3M
Q2 24
$859.6M
Q1 24
$832.8M
Total Debt
IMCR
IMCR
MPB
MPB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$438.7M
Q2 24
$452.5M
Q1 24
$452.5M
Stockholders' Equity
IMCR
IMCR
MPB
MPB
Q4 25
$381.0M
$814.1M
Q3 25
$396.6M
$796.3M
Q2 25
$388.5M
$775.7M
Q1 25
$378.5M
$667.9M
Q4 24
$360.7M
$655.0M
Q3 24
$377.8M
$573.1M
Q2 24
$359.1M
$559.7M
Q1 24
$359.5M
$551.0M
Total Assets
IMCR
IMCR
MPB
MPB
Q4 25
$1.1B
$6.1B
Q3 25
$1.1B
$6.3B
Q2 25
$1.1B
$6.4B
Q1 25
$1.0B
$5.5B
Q4 24
$1.0B
$5.5B
Q3 24
$1.1B
$5.5B
Q2 24
$1.0B
$5.4B
Q1 24
$994.0M
$5.3B
Debt / Equity
IMCR
IMCR
MPB
MPB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.16×
Q2 24
1.26×
Q1 24
1.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
MPB
MPB
Operating Cash FlowLast quarter
$-32.7M
$80.0M
Free Cash FlowOCF − Capex
$-35.5M
$71.8M
FCF MarginFCF / Revenue
-34.0%
115.8%
Capex IntensityCapex / Revenue
2.8%
13.3%
Cash ConversionOCF / Net Profit
4.12×
TTM Free Cash FlowTrailing 4 quarters
$-15.1M
$132.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
MPB
MPB
Q4 25
$-32.7M
$80.0M
Q3 25
$-4.5M
$26.3M
Q2 25
$26.0M
$29.0M
Q1 25
$435.0K
$11.5M
Q4 24
$-14.0M
$51.4M
Q3 24
$21.1M
$16.9M
Q2 24
$23.5M
$18.0M
Q1 24
$-4.6M
$12.4M
Free Cash Flow
IMCR
IMCR
MPB
MPB
Q4 25
$-35.5M
$71.8M
Q3 25
$-5.2M
$24.3M
Q2 25
$25.6M
$27.2M
Q1 25
$137.0K
$8.8M
Q4 24
$-17.5M
$44.5M
Q3 24
$20.3M
$16.8M
Q2 24
$23.1M
$17.7M
Q1 24
$-5.0M
$12.1M
FCF Margin
IMCR
IMCR
MPB
MPB
Q4 25
-34.0%
115.8%
Q3 25
-5.0%
39.4%
Q2 25
26.1%
50.1%
Q1 25
0.1%
18.4%
Q4 24
-20.9%
93.8%
Q3 24
25.3%
37.1%
Q2 24
30.7%
40.2%
Q1 24
-7.1%
28.5%
Capex Intensity
IMCR
IMCR
MPB
MPB
Q4 25
2.8%
13.3%
Q3 25
0.7%
3.1%
Q2 25
0.4%
3.2%
Q1 25
0.3%
5.7%
Q4 24
4.3%
14.6%
Q3 24
1.0%
0.0%
Q2 24
0.4%
0.7%
Q1 24
0.6%
0.8%
Cash Conversion
IMCR
IMCR
MPB
MPB
Q4 25
4.12×
Q3 25
1.44×
Q2 25
6.08×
Q1 25
0.09×
0.84×
Q4 24
3.88×
Q3 24
2.42×
1.37×
Q2 24
1.53×
Q1 24
1.02×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons